Cargando…

Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction

INTRODUCTION: Cardiovascular disease and myocardial infarction are leading causes of morbidity and mortality in aged populations. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are under evaluation as a therapeutic option for the treatment of myocardial infarction. AIM: This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellio, Michael A., Kanashiro-Takeuchi, Rosemeire M., Takeuchi, Lauro, Kulandavelu, Shathiyah, Lee, Yee-Shuan, Balkan, Wayne, Young, Karen C., Hare, Joshua M., Khan, Aisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804674/ https://www.ncbi.nlm.nih.gov/pubmed/35112111 http://dx.doi.org/10.20517/jca.2021.21

Ejemplares similares

S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction
por: Hatzistergos, Konstantinos E, et al.
Publicado: (2015)

S‐Nitrosoglutathione Reductase Deficiency Causes Aberrant Placental S‐Nitrosylation and Preeclampsia
por: Kulandavelu, Shathiyah, et al.
Publicado: (2022)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension
por: Sharma, Mayank, et al.
Publicado: (2022)

Thermostable Basic Fibroblast Growth Factor Enhances the Production and Activity of Human Wharton’s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles
por: Park, SangRok, et al.
Publicado: (2023)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor
por: Kanashiro-Takeuchi, Rosemeire M., et al.
Publicado: (2015)

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022)

Extracellular Vesicle-Derived microRNAs of Human Wharton’s Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis
por: Chinnici, Cinzia Maria, et al.
Publicado: (2021)

MicroRNA Cargo in Wharton’s Jelly MSC Small Extracellular Vesicles: Key Functionality to In Vitro Prevention and Treatment of Premature White Matter Injury
por: Tscherrig, Vera, et al.
Publicado: (2023)

Progenitor/Stem Cell Delivery by Suprarenal Aorta Route in Acute Kidney Injury
por: Rangel, Érika B., et al.
Publicado: (2019)

Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice
por: Kanashiro-Takeuchi, Rosemeire M., et al.
Publicado: (2022)

Fabrication and In Vitro Study of Tissue-Engineered Cartilage Scaffold Derived from Wharton's Jelly Extracellular Matrix
por: Xiao, Tongguang, et al.
Publicado: (2017)

Extracellular Matrix From Decellularized Wharton’s Jelly Improves the Behavior of Cells From Degenerated Intervertebral Disc
por: Penolazzi, Letizia, et al.
Publicado: (2020)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Human Wharton’s Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways
por: Joerger-Messerli, Marianne S., et al.
Publicado: (2021)

Multiplexed Molecular Imaging Strategy Integrated with RNA Sequencing in the Assessment of the Therapeutic Effect of Wharton’s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoporosis
por: Lu, Cheng-Hsiu, et al.
Publicado: (2021)

Extracellular Vesicles Derived from Wharton’s Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells
por: Joerger-Messerli, Marianne S., et al.
Publicado: (2018)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Abstract 126: Wharton’s Jelly Induces Osteogenesis In An Alveolar Cleft Model
por: Greives, Matthew R., et al.
Publicado: (2017)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
por: Talebi, Mehdi, et al.
Publicado: (2020)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2023)

Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)

Hypoxic Wharton's Jelly Stem Cell Conditioned Medium Induces Immunogenic Cell Death in Lymphoma Cells
por: Lin, Hao Daniel, et al.
Publicado: (2020)

Simultaneous Delivery of Wharton’s Jelly Mesenchymal Stem Cells and Insulin-Like Growth Factor-1 in Acute Myocardial Infarction
por: Rabbani, Shahram, et al.
Publicado: (2018)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f0d6k7gcoceg7494s2m4rseiqh